The UAR Openness Conference returns in June 2026
Due to the success of the 2024 Openness Conference and the overwhelming demand from conference attendees to do it again, we are delighted to announce that our second Openness Conference […]
Results from trontinemab Phase II trial presented at AAIC conference
Results from Roche’s Phase Ib/IIa trial of new Alzheimer’s drug trontinemab were presented at the Alzheimer’s Association International Conference (AAIC) in Toronto this week. The trial, known as Brainshuttle™ AD, […]
Immunotherapy Response May Be Influenced by Patient’s Own Autoantibodies
A landmark study headed by researchers at Yale School of Medicine and at Fred Hutchinson Cancer Center has revealed that autoantibodies (AAbs)—immune proteins traditionally associated with autoimmune disease—may profoundly influence […]
Exposure to the pesticide rotenone disrupts genes in Parkinson’s linked brain regions
Research led by Dr Sarah Marzi (UK DRI at King’s) with collaborators at Imperial College London and the University of Pittsburgh, reveals cells in key brain regions involved in Parkinson’s […]
Coronavirus infection treatment for cats gives insights on long COVID
US researchers have successfully treated cats with a severe coronavirus infection using a combination of stem cells and antiviral drugs, offering insights that could benefit both veterinary and human medicine. […]
Safer plastic for medical devices tested in human cells and rabbits
Belgian researchers have developed a new plastic for medical devices that is safe, non-toxic, 3D-printable, and has been tested in human cells and rabbits. Every year, millions of patients receive […]